EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

IDENTIFICATION OF NOCTURNAL HYPOGLYCEMIA BY FLASH GLUCOSE MONITORING IN PRIMARY CARE: A CASE REPORT AND REVIEW OF THE LITERATURE

XiuYing Mao, Lan Shen, NaNa Wang, HaiYing Zhang, Hua Yu, Ling Zhang, Ning Wang, HuiHua Jin, Jiang Yue

Journal of Pharmaceutical and Medical Research · 01.06.2026 · 8 (3) · 1-6

DOI: 10.61784/jpmr3078 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Pharmaceutical and Medical Research, online erschienen am 01.06.2026. Verfasst von XiuYing Mao und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore the clinical value of flash glucose monitoring (FGM) in community-based diabetes management through analysis of a case of nocturnal hypoglycemia identified by FGM.

Methods

A retrospective analysis was conducted on the clinical data of a 74-year-old male patient with type 2 diabetes mellitus. Because of persistently elevated fasting blood glucose levels (7.0-9.0 mmol/L), the patient had been self-adjusting multiple oral hypoglycemic agents over a prolonged period, including acarbose, sitagliptin phosphate, glipizide controlled-release tablets, dapagliflozin, and pioglitazone/metformin. FGM revealed nocturnal hypoglycemia, confirming the presence of the Somogyi phenomenon. Assessment using the Chinese version of the Diabetes Management Self-Efficacy Scale (C-DMSES) indicated low self-efficacy.

Results

Based on the FGM findings, the glucose-lowering regimen was adjusted by discontinuing glipizide controlled-release tablets and pioglitazone/metformin. Individualized dietary and exercise prescriptions, smoking cessation counseling, and psychological support were also provided. After intervention, the antidiabetic regimen was simplified, and no hypoglycemic events were detected on follow-up FGM. At 3 months, fasting blood glucose was 6.8 mmol/L, 2-hour postprandial blood glucose was 9.4 mmol/L, and glycated hemoglobin (HbA1c) was 6.9%. In addition, the C-DMSES score improved significantly.

Conclusion

FGM can effectively identify unrecognized nocturnal hypoglycemia in community-dwelling patients with diabetes and provide an objective basis for individualized and precise comprehensive management. For patients receiving multiple glucose-lowering agents and demonstrating low self-efficacy, FGM combined with a general practitioner-specialist collaborative care model may facilitate safe achievement of glycemic targets.

Zitieren

APA

Mao, X., Shen, L., Wang, N., Zhang, H., Yu, H., Zhang, L., Wang, N., Jin, H., & Yue, J. (2026). IDENTIFICATION OF NOCTURNAL HYPOGLYCEMIA BY FLASH GLUCOSE MONITORING IN PRIMARY CARE: A CASE REPORT AND REVIEW OF THE LITERATURE. Journal of Pharmaceutical and Medical Research, 8(3), 1-6. https://doi.org/10.61784/jpmr3078

Vancouver

Mao X, Shen L, Wang N, Zhang H, Yu H, Zhang L, et al. IDENTIFICATION OF NOCTURNAL HYPOGLYCEMIA BY FLASH GLUCOSE MONITORING IN PRIMARY CARE: A CASE REPORT AND REVIEW OF THE LITERATURE. Journal of Pharmaceutical and Medical Research. 2026;8(3):1-6. doi:10.61784/jpmr3078

BibTeX
@article{Mao2026,
  author = {Mao, XiuYing and Shen, Lan and Wang, NaNa and Zhang, HaiYing and Yu, Hua and Zhang, Ling and Wang, Ning and Jin, HuiHua and Yue, Jiang},
  title = {IDENTIFICATION OF NOCTURNAL HYPOGLYCEMIA BY FLASH GLUCOSE MONITORING IN PRIMARY CARE: A CASE REPORT AND REVIEW OF THE LITERATURE},
  journal = {Journal of Pharmaceutical and Medical Research},
  year = {2026},
  volume = {8},
  number = {3},
  pages = {1--6},
  doi = {10.61784/jpmr3078}
}
Kostenlos starten →